Acute myocarditis after massive phenelzine overdose
- PMID: 17823790
- DOI: 10.1007/s00228-007-0360-y
Acute myocarditis after massive phenelzine overdose
Abstract
Background: Monoamine oxidase inhibitors (MAOIs) are uncommonly used due to their high frequency of adverse effects, including tachycardia and hypertension. Recently, there has been renewed interest in the role of this class of drugs in treating a variety of psychiatric disorders. The clinical features of MAOI overdose are poorly characterised. This paper describes a novel cardiac complication of phenelzine toxicity in a previously healthy young adult with no history of cardiovascular disease.
Methods: A 23-year-old woman presented to hospital after massive phenelzine overdose, and the clinical features and pathological findings are discussed in light of existing literature.
Results: Clinical features of phenelzine toxicity included reduced consciousness level, seizures, and tachycardia, in keeping with previous reports. Unexpectedly, the patient developed severe and unexplained hypotension and impaired left ventricular function, and died 3 days after initial presentation. Post-mortem examination confirmed high serum phenelzine concentrations (4.1 mg/L) and histopathological features that were consistent with drug-induced acute myocarditis.
Conclusion: Acute myocarditis was attributed to phenelzine in the absence of any plausible alternative explanation. This possible complication should be considered in patients who develop unexplained hypotension after phenelzine overdose.
Similar articles
-
"Ping-pong" gaze in severe monoamine oxidase inhibitor toxicity.J Emerg Med. 1995 Sep-Oct;13(5):653-5. doi: 10.1016/0736-4679(95)00072-i. J Emerg Med. 1995. PMID: 8530785
-
Monoamine oxidase inhibitor overdose.Ann Emerg Med. 1984 Dec;13(12):1137-44. doi: 10.1016/s0196-0644(84)80339-x. Ann Emerg Med. 1984. PMID: 6391305 Review.
-
Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s.J Accid Emerg Med. 1995 Mar;12(1):49-51. doi: 10.1136/emj.12.1.49. J Accid Emerg Med. 1995. PMID: 7640830 Free PMC article.
-
Two fatalities involving phenelzine.J Anal Toxicol. 1995 Jul-Aug;19(4):265-6. doi: 10.1093/jat/19.4.265. J Anal Toxicol. 1995. PMID: 8531475
-
Phenelzine use throughout pregnancy and the puerperium: case report, review of the literature, and management recommendations.Depress Anxiety. 1997;6(3):124-8. Depress Anxiety. 1997. PMID: 9442987 Review.
Cited by
-
Clinical use of antidepressant therapy and associated cardiovascular risk.Drug Healthc Patient Saf. 2012;4:93-101. doi: 10.2147/DHPS.S28804. Epub 2012 Aug 17. Drug Healthc Patient Saf. 2012. PMID: 22936860 Free PMC article.
-
Body fat reduction without cardiovascular changes in mice after oral treatment with the MAO inhibitor phenelzine.Br J Pharmacol. 2018 Jun;175(12):2428-2440. doi: 10.1111/bph.14211. Epub 2018 May 6. Br J Pharmacol. 2018. PMID: 29582416 Free PMC article.
-
Phenelzine (monoamine oxidase inhibitor) increases production of nitric oxide and proinflammatory cytokines via the NF-κB pathway in lipopolysaccharide-activated microglia cells.Neurochem Res. 2012 Oct;37(10):2117-24. doi: 10.1007/s11064-012-0833-y. Epub 2012 Jul 5. Neurochem Res. 2012. PMID: 22763802
-
Cardiovascular considerations in antidepressant therapy: an evidence-based review.J Tehran Heart Cent. 2013 Oct 28;8(4):169-76. J Tehran Heart Cent. 2013. PMID: 26005484 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources